Home/Investors/Lilly Asia Ventures Lilly Asia Ventures
Biotech Investor · 25 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Tenacia Biotechnology | phase-1 | — | Oncology, Immunology |
| InventisBio | phase-2 | — | Oncology, Metabolic Diseases |
| Impact Therapeutics | phase-3 | — | Oncology |
| ImmuneOnco Biopharma | phase-2 | — | Oncology, Immunology |
| GenFleet Therapeutics | phase-2 | — | Oncology, Immunology |
| EpimAb Biotherapeutics | phase-2 | — | Oncology, Immunology |
| Duality Biologics | phase-1 | — | Oncology |
| CStone Pharmaceuticals | commercial | — | Oncology, Immunology |
| Conjustar | phase-1 | — | Oncology |
| Abbisko Therapeutics | phase-2 | — | Oncology |
| East Mab | phase-1 | — | Oncology, Immunology |
| Sonoma Biotherapeutics | Phase 1 | — | Autoimmune Diseases, Inflammatory Diseases |
| TransThera Sciences | phase-2 | — | Oncology, Immunology |
| Hepagene Therapeutics | phase-2 | — | Infectious Disease, Metabolic |
| Biosion | phase-2 | — | Oncology, Immunology |
| Raffles PharmaTech | phase-2 | — | Oncology, Metabolic Diseases |
| Innorna | preclinical | — | Genetics & Genomics, Oncology |
| Doer Biologics | phase-1 | — | Oncology, Immunology |
| TCRCure | phase-1 | — | Oncology, Infectious Disease |
| Keymed Biosciences | phase-2 | — | Oncology, Immunology |
| GrandOmics Biosciences | commercial | — | Genetics & Genomics, Diagnostics |
| CorreGene | preclinical | — | Rare Disease, Gene Therapy |
| C-Ray Therapeutics | phase-1 | — | Oncology, Antibodies |
| BriSTAR Immunotech | phase-1 | — | Oncology, Immunology |
| Ascentawits Pharmaceuticals | preclinical | — | Oncology, Immunology |